Nichi-Asia Life Science (Niscell) owns technology and materials for isolation, processing and expansion of clinically usable stem cells. The company also provides facilitation to doctors and hospitals to regenerate health with immunotherapy (Autologous Immune Enhancement Therapy (AIET) ) and Stem Cells. The company is a licensed Private Blood Bank by the Ministry of Health, Malaysia.